Remuneration Committee

John Garcia: Chairman, Independent Non-executive Director

John Garcia was appointed to the Board of the Company in September 2007. With a 25-year career in the health products industry, he has been instrumental in the development and growth of several medical products and services companies. He served for more than ten years as President of Sulzermedica’s US$300m pacemaker business before it was acquired by Guidant in 1998. He also held sales and marketing management positions with FHP (a California HMO), BioScience (a national reference lab) and Pharmaseal (a division of American Hospital Supply Corporation).

Eric Swenden: Non-Executive Director

Eric Swenden was appointed to the Board of the Company in 2003. He has had a long and successful career in finance and company management having held positions on the boards of the broad array of public and private companies, including several drug companies, Vandemoortele Food Group and General Bank (Belgium’s largest bank before its merger with Fortis).

Responsibilities of the Remuneration Committee

The Remuneration Committee is comprised of John Garcia (Chairman), and Eric Swenden. The Remuneration Committee is responsible for determining or making recommendations to the Board with respect to the proper compensation of Directors in connection with their service to the Company, the remuneration and terms of employment of executive officers and employees of the Company and the grant of stock options, restricted stock and other incentive compensation arrangements to Directors, executive officers and employees of the Company.